openPR Logo
Press release

Research Focused on the CNS Lymphoma Market Forecast up to 2020

09-07-2017 10:00 AM CET | Health & Medicine

Press release from: Transparency Market Research

Research Focused on the CNS Lymphoma Market Forecast up to 2020

Central Nervous System (CNS) lymphoma is also known as primary CNS lymphoma and microglioma, is a type of intracranial tumor observed in patients diagnosed with severe immunosupression (typically patients with AIDS). Primary CNS lymphoma initiates in the spinal cord, brain or meninges. While, most of primary CNS lymphomas are B-cell lymphomas and T-cell lymphomas are rare. The sign and symptoms of primary CNS lymphoma are diplopia, dysphagia, vertigo, monocular vision loss, progressive dementia and facial hypoesthesia. Focal neurological deficit is the most common sign observed in patients affected with CNS lymphoma, followed by neuropsychiatric symptoms, headache/nausea/vomiting due to increased intracranial pressure and seizures.

Obtain Report Details @ http://www.transparencymarketresearch.com/cns-lymphoma-market.html

According to World Health Organization (WHO), in 2012 it was witnessed that the prevalence of primary CNS lymphoma substantially increased in couple of decades and represented up to 7% of intracranial tumors around the world for the year. The past increase was partly assisted with growing prevalence of AIDS as well as immunosuppression in solid organ transplant patients. According to a survey carried out by WHO, where they reported that Indolent lymphomas and diffuse large cell B-cell lymphomas have high prevalence rate compared to mantle cell lymphoma, peripheral T-cell lymphoma and composite lymphomas.

CNS lymphoma is diagnosed with various tests and procedures are as follows:

-Physical exam
-Neurological exam
-Slit-lamp eye exam
-MRI (magnetic resonance imaging)
-CT (computed topography )scan
-PET scan (positron emission tomography scan)
-Lumbar puncture
-Stereotactic biopsy
-Complete blood count (CBC) with differential
-Blood chemistry studies

There are some tests that are carried out on the samples of tissues removed from patient’s body such as flow cytometry, immunohistochemistry and cytogenic analysis. The treatment regime of CNS lymphoma consists of corticosteroids (e.g. prednisolone), chemotherapy (methotrexate with leucovorin), radiation therapy (whole brain radiation therapy) and surgery (stereotactic biopsy). In patients diagnosed with AIDS highly active anti-retroviral therapy (HAART) is used, that affects the CD4+ lymphocytes and the level of immunosuppression observed in the patients. CNS lymphoma is treated with two types of chemotherapies such as intrathecal chemotherapy or intraventricular chemotherapy especially depended on the dose of methotrexate.

-The pipeline review of CNS lymphoma drugs comprises upcoming drugs as follows:
Alimta
-Filgrastim + Rituximab + Methotrexate + Leucovorin + Temozolomide + Cytarabine + Etoposide
-Autologous Immunoglobulin Idiotype-KLH Conjugate Vaccine + Methotrexate + Thiotepa + Sargramostim + Radiation
-Methotrexate + Leucovorin + Dexamethasone
-Idarubicin + Methotrexate + Filgrastim + Ara-C
-procarbazine + lomustine + vincristine + radiation therapy
-HAART + Methotrexate + Rituximab + Leucovorin
-Rituximab + Methotrexate + Teniposide + BCNU + Prednisolone + ARA-C + Radiation Therapy

North America was observed to be the largest market for CNS lymphoma drugs diagnosis and treatment. Advanced technologies and high healthcare awareness are the major factors driving the growth of this market during the study period from 2014 to 2020. Europe was observed to be the second largest market and one of the leading research destinations for neurological and carcinogenic diseases diagnosis and treatment.

Make an Enquiry @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3163

Asia-Pacific and Rest of the World were observed to be the most potential markets for CNS lymphoma drugs diagnosis and treatment market. These regions lack in advanced infrastructure and disease awareness. The future growth in these geographical regions is expected due to the presence of emerging economies such as China, India, Brazil and other countries that primarily prefer healthcare sector for developmental investment.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Research Focused on the CNS Lymphoma Market Forecast up to 2020 here

News-ID: 702272 • Views: 127

More Releases from Transparency Market Research

Global Waste to Energy Market is Presumed to be Valued at US$ 32 Bn by 2026
Overview TMR’s report on the Waste-to-energy Technologies Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Waste-to-energy Technologies Market serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Waste-to-energy Technologies Market over the forecast period.
FPSO Market is Likely to Reach a Value of US$ 66 Bn by 2026
Overview TMR’s report on the FPSO Vessels and Equipments Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the FPSO Vessels and Equipments Market serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the FPSO Vessels and
Recycled Plastic & Plastic Waste to Oil Market Demand and Growth Analysis with F …
Overview TMR’s report on the Recycled Plastics & Plastic Waste to Oil Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Recycled Plastics & Plastic Waste to Oil Market serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely
Chlorinated Paraffins Market – Size will Observe Lucrative Surge by the End202 …
Overview TMR’s report on the Chlorinated Paraffin Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Chlorinated Paraffin Market serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Chlorinated Paraffin Market over the forecast period.

All 5 Releases


More Releases for CNS

Neuro Critical Care Market Insights in terms of volume and value 2018 to 2028(Mo …
Neuro critical care is an emerging field that combines the specialties that link neurology, neurosurgery, and critical care. Just as the field has evolved from primary focus on post-operative care to elective neurosurgical patients, the focus towards the resuscitation of neurological emergency cases such as traumatic brain injury or subarachnoid hemorrhage, which remain a clinical challenge. The neuro critical care market is strongly driven by the increasing focus, awareness, and
Global CNS Therapeutics Market Size, Status and Forecast 2018-2025
CNS Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the CNS Therapeutics development in United States, Europe and China. Get Sample@ https://www.researchbeam.com/global-cns-therapeutics-size-status-and-forecast-2018-2025-market/request-sample Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage
CNS Lymphoma Market Key Trends and Opportunity Analysis 2020
Central Nervous System (CNS) lymphoma is also known as primary CNS lymphoma and microglioma, is a type of intracranial tumor observed in patients diagnosed with severe immunosupression (typically patients with AIDS). Primary CNS lymphoma initiates in the spinal cord, brain or meninges. While, most of primary CNS lymphomas are B-cell lymphomas and T-cell lymphomas are rare. The sign and symptoms of primary CNS lymphoma are diplopia, dysphagia, vertigo, monocular vision
CNS Cluster Addiction Drug Development Pipeline Review, 2017
ReportsWorldwide has announced the addition of a new report title CNS Cluster Addiction Drug Development Pipeline Review, 2017 to its growing collection of premium market research reports. The central nervous system (CNS) addiction cluster report provides an overview of the CNS Clusters pipeline landscape. The report provides comprehensive information on the therapeutics under development, and key players involved in therapeutic development for Alcohol Addiction, Drug Addiction, Nicotine Addiction, Opium (Opioid) Addiction
US CNS Disorders Drug Pipeline Insight 2014
The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry. In US, the numbers of CNS disorders have increased at an alarming rate, while the available therapies were unable to meet the market requirements. There has been steady to rapid growth in the market for CNS disorder, especially over the past two decades. The market for CNS therapies is one of the
CNS Therapeutics Market Research Report 2016
“Global CNS Therapeutics Market Research Report 2016” Order This Report by calling BigMarketResearch.com at +1-971-202-1575 Notes: Production, means the output of CNS Therapeutics Revenue, means the sales value of CNS Therapeutics This report studies CNS Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering Pfizer, Inc. (USA) Johnson & Johnson (USA) Bristol-Myers Squibb